For example, the degree of inflammation impacts on the microbial profile in IBD and effective IBD medications (such as anti-TNF-α agents) seem to restore at least in part many of the microbial defects in IBD patients [108]. This evidence concerns the gene TNF and irritable bowel syndrome.